Anterolateral Versus Direct Lateral Approach in Hemiarthroplasty for Hip Fracture: A Randomised Study
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Hip Fractures
- Sponsor
- Sykehuset Innlandet HF
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Harris Hip Score (HHS)
- Status
- Active, Not Recruiting
- Last Updated
- 11 months ago
Overview
Brief Summary
Patients with dislocated hip fractures are randomised to cemented hemiarthroplasty with an anterolateral approach or a direct lateral approach.
Detailed Description
Dislocated intracapsular hip fractures are usually treated with cemented hemiarthroplasty. In Norway, a direct lateral approach is most often used, as recommended in national guidelines. In total hip arthroplasty, however, minimally invasive approaches are also commonly used, and may improve the clinical results, as compared to posterior or direct lateral approaches. The aims of the present study are to evaluate the effect of the minimally invasive anterolateral approach (Watson-Jones approach) compared to the direct lateral approach (Hardinge approach) to the hip joint in hemiarthroplasty after dislocated hip fractures. Patients with dislocated hip fractures who are fit for cemented hemiarthroplasty are randomised to surgery with an anterolateral approach or a direct lateral approach.
Investigators
Eligibility Criteria
Inclusion Criteria
- •dislocated hip fracture.
- •planned cemented hemiarthroplasty.
- •able to walk, with or without walking aids, prior to the injury.
Exclusion Criteria
- •young and healthy patients with displaced hip fractures who are recommended total hip arthroplasty or open reduction / internal fixation of the fracture.
- •patients with severe comorbidity and high risk of cement-related complications who are recommended uncemented hemiarthroplasty (some, but not all, patients with ASA (American Society of Anesthesiologists) grade 4).
- •not able to give informed consent.
Outcomes
Primary Outcomes
Harris Hip Score (HHS)
Time Frame: 12 months
Harris Hip Score (HHS) is an outcome measure for hip-related symptoms. The score is based on both patient-reported information and clinical examination, and is administered by a qualified health care professional. It covers four domains: Pain, function, absence of deformity and range of motion. The score ranges from 0 (worst) to 100 (best).
Secondary Outcomes
- EuroQol questionnaire (EQ-5D)(12 months)
- Patient-reported limping(12 months)
- Timed Up and Go (TUG)(12 months)
- Adverse events(12 months)
- Cause of death(12 months)
- Blood loss(During surgery)
- Duration of surgery(During surgery)
- Patient-reported use of walking aid(12 months)
- Trendelenburg test(12 months)
- Length of hospital stay(12 months)
- Mortality(12 months)